|
InnaVirVax announces publication of an article in JAIDS (Journal of Acquired …
PharmaLive (press release) (subscription) Entitled “Specific Anti-gp41 Antibodies Predict HIV-1 Disease Progression”, this article highlights the protective role of anti-3S antibodies in the progression of HIV infection. Evry, 1st March 2013 – InnaVirVax, a biopharmaceutical company … |
Cancer tumours halt immune responseHealthCanal.comThe most common, IgG, comprises 4 types (or subclasses) of which the researchers have shown that IgG1 subclass antibodies are the most effective at activating immune cells, while antibodies of the IgG4 …
|
Tumors Create Conditions That Weaken Immune Response
Medical News Today The researchers engineered IgG1 and IgG4 antibodies against a tumor antigen. They identified that IgG4 wasn’t as efficient IgG1 in triggering immune cells to kill cancer cells. In addition, IgG4 prevented the IgG1 antibody from effectively killing … Tumours deliberately create conditions that inhibit body’s best immune …Exchange Morning Post (press release) |
|
Immune system ‘powerless to stop skin cancer’
CANOE Previous work from the team at King’s College London showed that while patients with melanoma produced antibodies that could attack tumour cells, the immune system often seemed powerless to stop the cancer progressing. But, they say their latest … |
|
German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes …
The Herald | HeraldOnline.com The European Medicines Agency’s (the “EMA”) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who … |
 BBC News |
Skin cancer ‘able to fight off body’s immune system’
BBC News Previous work from the team at King’s College London showed that while patients with melanoma produced antibodies that could attack tumour cells, the immune system often seemed powerless to stop the cancer progressing. But in the latest research they … |
|
Tumors Deliberately Create Conditions That Inhibit Body’s Best Immune Response
Science Daily (press release) The most common, IgG, comprises 4 types (or subclasses) of which the researchers have shown that IgG1 subclass antibodies are the most effective at activating immune cells, while antibodies of the IgG4 subclass are thought to be the least efficient. |
|
UT neurologist to study how antibodies attack
WBBJ-TV Dr. Michael Levin will use the $650,000 in funding to study how an MS patient’s own antibodies attack nerve cells in the brain and spinal cord. Traditionally, the immune response was thought only to destroy the protective coating of nerve cells, known … |
Business StandardRoche dropping Herceptin price in India by 30%FiercePharmaHe said Roche would drop the price of trastuzumab in India from its current 110,700 rupees ($2,000) to 75,000 rupees, a 31% drop. Rituximab would be reduced from about $1,456 a …
|
UT neurologist to study how antibodies attack
Knoxville News Sentinel Dr. Michael Levin will use the $650,000 in funding to study how an MS patient’s own antibodies attack nerve cells in the brain and spinal cord. Traditionally, the immune response was thought only to destroy the protective coating of nerve cells, known … |